CompletedPhase 2NCT02472769
IBP-9414 for the Prevention of Necrotizing Enterocolitis
Studying Necrotizing enterocolitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Infant Bacterial Therapeutics
- Principal Investigator
- Josef Neu, MDUniversity of Florida College of Medicine, Gainsville, FL
- Intervention
- IBP-9414(drug)
- Enrollment
- 120 target
- Eligibility
- All sexes
- Timeline
- 2016 – 2017
Study locations (15)
- Univ. Arkansas Medical Sciences, Little Rock, Arkansas, United States
- UCLA Medical Center, Los Angeles, California, United States
- University Florida Health, Gainesville, Florida, United States
- Wolfson Children´s Hospital, Jacksonville, Florida, United States
- UF Health Jacksonville, Jacksonville, Florida, United States
- Jackson Memorial Hospital, Miami, Florida, United States
- Memorial Hospital of South Bend, South Bend, Indiana, United States
- Wesley Medical Center, Wichita, Kansas, United States
- Kings County Hospital Center, Brooklyn, New York, United States
- Duke University Medical Center, Durham, North Carolina, United States
- Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
- Hahnemann University Hospital, Philadelphia, Pennsylvania, United States
- Einstein Medical Center of Philadelphia, Philadelphia, Pennsylvania, United States
- Jackson Madison County General Hospital, Jackson, Tennessee, United States
- Timpanogos Regional Hospital, Orem, Utah, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02472769 on ClinicalTrials.govOther trials for Necrotizing enterocolitis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07490834Long-term Nutritional Impact of Necrotizing Enterocolitis in Premature Newborns.Central Hospital, Nancy, France
- RECRUITINGNCT07192393Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).Imperial College London
- RECRUITINGNANCT06727877Predictive Diagnosis of Ulcero-Necrotizing EnteroColitis in Premature Babies Using an Artificial Intelligence Approach Based on Early Analysis of the Fecal MicrobiotaUniversity Hospital, Clermont-Ferrand
- RECRUITINGNCT06681129Study of Normal Intestinal Development and Disease in Premature and Term NeonatesBoston Children's Hospital
- ACTIVE NOT RECRUITINGNCT06850896Antibiotic Exposure on Gut Microbiota and Motility Establishment in NewbornsThe First Hospital of Jilin University
- RECRUITINGNCT07152106Amniotic Fluid & the Preterm GutMaxima Medical Center
- ACTIVE NOT RECRUITINGNANCT06908239Milk Temperature Control and Necrotizing Enterocolitis Risk in Extremely Preterm InfantsDaping Hospital and the Research Institute of Surgery of the Third Military Medical University
- RECRUITINGNANCT06672913Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter StudyBaskent University Ankara Hospital